SCHEMBL19806093

SCHEMBL19806093

CSc1nc(-c2ccc(=O)[nH]c2)c2ccccc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.47
ALDH1A1 P00352 7/20 0.47
MAPT P10636 5/20 0.47
LMNA P02545 4/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
THRB P10828 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
HTT P42858 2/20 0.44
TDP1 Q9NUW8 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
RXFP1 Q9HBX9 1/20 0.42
ELANE P08246 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HPGD P15428 1/20 0.39
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20203648 0.79 KDM4E (0.67) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL19806092 0.69 ADORA2A (0.48) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL8325338 0.69 KDM4E (0.74) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL29532939 0.69 KDM4E (0.74) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL31387707 0.68 KDM4E (0.51) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL21019879 0.67 PDK1 (0.39) KDM4EALDH1A1MAPTL3MBTL1THRB
SCHEMBL21019931 0.67 ALDH1A1 (0.40) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL24175003 0.66 KDM4E (0.61) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL694974 0.65 MAPT (0.48) KDM4EALDH1A1MAPTL3MBTL1THRB
SCHEMBL3816236 0.65 KDM4E (0.59) KDM4EALDH1A1MAPTLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 US disclosed
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 US disclosed
US-20210309647-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-10-07 US disclosed
EP-3484854-B1 APOPTOSIS INHIBITORS NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) 2021-01-20 EP disclosed
US-20190152960-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2019-05-23 US disclosed
WO-2018014802-A1 APOPTOSIS INHIBITORS NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2018-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152960-A1 Apoptosis Inhibitors BAX, SDHA, SDHB KDM4E 1117/4885ALDH1A1 550/4885MAPT 2304/4885
US-11725000-B2 Apoptosis inhibitors BAX, SDHA, SDHB KDM4E 1117/4885ALDH1A1 550/4885MAPT 2304/4885
US-20210309647-A1 Apoptosis Inhibitors BAX, SDHA, SDHB KDM4E 1117/4885ALDH1A1 550/4885MAPT 2304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.